These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36539349)

  • 1. Discovery of Spiro[pyrrolidine-3,3'-oxindole] LXRβ Agonists for the Treatment of Osteoporosis.
    Chen H; Hua P; Huang D; Zhang Y; Zhou H; Xu J; Gu Q
    J Med Chem; 2023 Jan; 66(1):752-765. PubMed ID: 36539349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of new LXRβ agonists as glioblastoma inhibitors.
    Chen H; Chen Z; Zhang Z; Li Y; Zhang S; Jiang F; Wei J; Ding P; Zhou H; Gu Q; Xu J
    Eur J Med Chem; 2020 May; 194():112240. PubMed ID: 32248003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of liver X receptor (LXR) inhibits receptor activator of nuclear factor κB ligand (RANKL)-induced osteoclast differentiation in an LXRβ-dependent mechanism.
    Remen KM; Henning P; Lerner UH; Gustafsson JÅ; Andersson G
    J Biol Chem; 2011 Sep; 286(38):33084-94. PubMed ID: 21784849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesterol-sensing receptors, liver X receptor alpha and beta, have novel and distinct roles in osteoclast differentiation and activation.
    Robertson KM; Norgård M; Windahl SH; Hultenby K; Ohlsson C; Andersson G; Gustafsson JA
    J Bone Miner Res; 2006 Aug; 21(8):1276-87. PubMed ID: 16869726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver X receptor activation inhibits osteoclastogenesis by suppressing NF-κB activity and c-Fos induction and prevents inflammatory bone loss in mice.
    Kim HJ; Yoon KA; Yoon HJ; Hong JM; Lee MJ; Lee IK; Kim SY
    J Leukoc Biol; 2013 Jul; 94(1):99-107. PubMed ID: 23657115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver X receptors orchestrate osteoblast/osteoclast crosstalk and counteract pathologic bone loss.
    Kleyer A; Scholtysek C; Bottesch E; Hillienhof U; Beyer C; Distler JH; Tuckermann JP; Schett G; Krönke G
    J Bone Miner Res; 2012 Dec; 27(12):2442-51. PubMed ID: 22806960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knock-down of the oxysterol receptor LXRα impairs cholesterol efflux in human primary macrophages: lack of compensation by LXRβ activation.
    Ishibashi M; Filomenko R; Rébé C; Chevriaux A; Varin A; Derangère V; Bessède G; Gambert P; Lagrost L; Masson D
    Biochem Pharmacol; 2013 Jul; 86(1):122-9. PubMed ID: 23313547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the liver X receptor-β potently inhibits osteoclastogenesis from lipopolysaccharide-exposed bone marrow-derived macrophages.
    Robertson Remen KM; Lerner UH; Gustafsson JÅ; Andersson G
    J Leukoc Biol; 2013 Jan; 93(1):71-82. PubMed ID: 23099324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LXR{beta} is the dominant LXR subtype in skeletal muscle regulating lipogenesis and cholesterol efflux.
    Hessvik NP; Boekschoten MV; Baltzersen MA; Kersten S; Xu X; Andersén H; Rustan AC; Thoresen GH
    Am J Physiol Endocrinol Metab; 2010 Mar; 298(3):E602-13. PubMed ID: 19996385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting selective liver X receptor β agonists using multiple machine learning methods.
    Li Y; Wang L; Liu Z; Li C; Xu J; Gu Q; Xu J
    Mol Biosyst; 2015 May; 11(5):1241-50. PubMed ID: 25734698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver X receptor: a potential target in the treatment of atherosclerosis.
    Savla SR; Prabhavalkar KS; Bhatt LK
    Expert Opin Ther Targets; 2022 Jul; 26(7):645-658. PubMed ID: 36003057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LXRβ Activation Inhibits the Proliferation of Small-cell Lung Cancer Cells by Depleting Cellular Cholesterol.
    Kashiwagi K; Sato-Yazawa H; Ishii J; Kohno K; Tatsuta I; Miyazawa T; Takagi M; Chiba H; Yazawa T
    Anticancer Res; 2022 Jun; 42(6):2923-2930. PubMed ID: 35641269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 24(S)-Saringosterol from edible marine seaweed Sargassum fusiforme is a novel selective LXRβ agonist.
    Chen Z; Liu J; Fu Z; Ye C; Zhang R; Song Y; Zhang Y; Li H; Ying H; Liu H
    J Agric Food Chem; 2014 Jul; 62(26):6130-7. PubMed ID: 24927286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-dimensional pharmacophore modeling of liver-X receptor agonists.
    Zhao W; Gu Q; Wang L; Ge H; Li J; Xu J
    J Chem Inf Model; 2011 Sep; 51(9):2147-55. PubMed ID: 21434646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesterol efflux is LXRα isoform-dependent in human macrophages.
    Ma AZ; Song ZY; Zhang Q
    BMC Cardiovasc Disord; 2014 Jul; 14():80. PubMed ID: 24996838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage-independent regulation of reverse cholesterol transport by liver X receptors.
    Breevoort SR; Angdisen J; Schulman IG
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1650-60. PubMed ID: 24947527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic LXR agonist inhibits the development of atherosclerosis in New Zealand White rabbits.
    Honzumi S; Shima A; Hiroshima A; Koieyama T; Terasaka N
    Biochim Biophys Acta; 2011 Dec; 1811(12):1136-45. PubMed ID: 21875689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skeletal muscle as a target of LXR agonist after long-term treatment: focus on lipid homeostasis.
    Archer A; Laurencikiene J; Ahmed O; Steffensen KR; Parini P; Gustafsson JÅ; Korach-André M
    Am J Physiol Endocrinol Metab; 2014 Mar; 306(5):E494-502. PubMed ID: 24368671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver X receptor agonist methyl-3β-hydroxy-5α,6α-epoxycholanate attenuates atherosclerosis in apolipoprotein E knockout mice without increasing plasma triglyceride.
    Yan W; Zhang T; Cheng J; Zhou X; Qu X; Hu H
    Pharmacology; 2010; 86(5-6):306-12. PubMed ID: 21071998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver LXRα expression is crucial for whole body cholesterol homeostasis and reverse cholesterol transport in mice.
    Zhang Y; Breevoort SR; Angdisen J; Fu M; Schmidt DR; Holmstrom SR; Kliewer SA; Mangelsdorf DJ; Schulman IG
    J Clin Invest; 2012 May; 122(5):1688-99. PubMed ID: 22484817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.